25M Investview (INVU) stock options granted to director Verdun

Rhea-AI Filing Summary

Investview director Robert Verdun was granted stock options for 25,000,000 shares of common stock on January 28, 2026 at an exercise price of $0.05 per share. These options are direct holdings.

According to the vesting schedule, 5,000,000 shares vest on each of February 5, 2027, 2028, 2029, 2030, and 2031. After this grant, Verdun directly owns 1,050,000 shares of Investview common stock, separate from the option position.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Verdun Robert

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	25,000,000	$0.00	--
holding	Common Stock, par value $0.001	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 25,000,000 shares (Direct); Common Stock, par value $0.001 — 1,050,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verdun Robert

(Last) (First) (Middle)

521 WEST LANCASTER AVENUE,

SECOND FLOOR

(Street)

HAVERFORD, PA 19041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Investview, Inc. [ INVU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.001								1,050,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$0.05	01/28/2026		A		25,000,000		(1)	01/28/2033	Common Stock	25,000,000	$0	25,000,000	D

Explanation of Responses:

1. 5,000,000 shares vest on each of February 5, 2027, February 5, 2028, February 5, 2029, February 5, 2030, and February 5, 2031.

	/s/ Robert Verdun	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Investview (INVU) director Robert Verdun receive in this Form 4 filing?

Director Robert Verdun received stock options for 25,000,000 shares of Investview common stock at an exercise price of $0.05 per share. The filing also shows his directly held common stock position after this grant.

What is the vesting schedule for Robert Verdun’s Investview (INVU) stock options?

The options vest in five equal tranches of 5,000,000 shares each. Vesting occurs on February 5 of 2027, 2028, 2029, 2030, and 2031, spreading the potential ownership increase over several years.

What is the exercise price of Robert Verdun’s Investview (INVU) stock options?

The stock options reported have an exercise price of $0.05 per share. This means Verdun can buy Investview common stock at $0.05 per share for the optioned amount if and when the options are vested and exercised.

How many Investview (INVU) common shares does Robert Verdun own after this transaction?

After the reported transaction, Verdun directly holds 1,050,000 shares of Investview common stock. This figure reflects his beneficial ownership of the underlying stock, separate from the newly granted 25,000,000 stock options.

When do Robert Verdun’s Investview (INVU) stock options expire?

The stock options reported in the filing have an expiration date of January 28, 2033. Verdun can exercise vested options up to that date, subject to the vesting schedule and any applicable company or regulatory requirements.